JP2009505960A5 - - Google Patents

Download PDF

Info

Publication number
JP2009505960A5
JP2009505960A5 JP2008524052A JP2008524052A JP2009505960A5 JP 2009505960 A5 JP2009505960 A5 JP 2009505960A5 JP 2008524052 A JP2008524052 A JP 2008524052A JP 2008524052 A JP2008524052 A JP 2008524052A JP 2009505960 A5 JP2009505960 A5 JP 2009505960A5
Authority
JP
Japan
Prior art keywords
optionally substituted
optionally
alkyl
substituted
alkynyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008524052A
Other languages
English (en)
Japanese (ja)
Other versions
JP5149177B2 (ja
JP2009505960A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/028801 external-priority patent/WO2007014198A1/en
Publication of JP2009505960A publication Critical patent/JP2009505960A/ja
Publication of JP2009505960A5 publication Critical patent/JP2009505960A5/ja
Application granted granted Critical
Publication of JP5149177B2 publication Critical patent/JP5149177B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2008524052A 2005-07-25 2006-07-24 増殖性疾患の治療のための、チューブリンポリマー化の1,2,3−トリアゾール系抑制剤 Expired - Fee Related JP5149177B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US70223705P 2005-07-25 2005-07-25
US60/702,237 2005-07-25
US74941805P 2005-12-12 2005-12-12
US60/749,418 2005-12-12
US78048806P 2006-03-08 2006-03-08
US60/780,488 2006-03-08
PCT/US2006/028801 WO2007014198A1 (en) 2005-07-25 2006-07-24 1, 2, 3 -triazoles inhibitors of tubulin polymerization for the treatment of poliferative disorders

Publications (3)

Publication Number Publication Date
JP2009505960A JP2009505960A (ja) 2009-02-12
JP2009505960A5 true JP2009505960A5 (cg-RX-API-DMAC10.html) 2009-09-10
JP5149177B2 JP5149177B2 (ja) 2013-02-20

Family

ID=37478877

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008524052A Expired - Fee Related JP5149177B2 (ja) 2005-07-25 2006-07-24 増殖性疾患の治療のための、チューブリンポリマー化の1,2,3−トリアゾール系抑制剤

Country Status (8)

Country Link
US (4) US7781462B2 (cg-RX-API-DMAC10.html)
EP (1) EP1919881B1 (cg-RX-API-DMAC10.html)
JP (1) JP5149177B2 (cg-RX-API-DMAC10.html)
AU (1) AU2006272652B2 (cg-RX-API-DMAC10.html)
CA (1) CA2614919C (cg-RX-API-DMAC10.html)
ES (1) ES2408597T3 (cg-RX-API-DMAC10.html)
TW (1) TWI462908B (cg-RX-API-DMAC10.html)
WO (1) WO2007014198A1 (cg-RX-API-DMAC10.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5149177B2 (ja) 2005-07-25 2013-02-20 シンタ ファーマシューティカルズ コーポレーション 増殖性疾患の治療のための、チューブリンポリマー化の1,2,3−トリアゾール系抑制剤
US8742133B2 (en) * 2007-08-13 2014-06-03 Synta Pharmaceuticals Corp. Triazole compounds that modulate HSP90 activity
US9205086B2 (en) 2010-04-19 2015-12-08 Synta Pharmaceuticals Corp. Cancer therapy using a combination of a Hsp90 inhibitory compounds and a EGFR inhibitor
BR112012029647A2 (pt) 2010-05-21 2016-08-02 Chemilia Ab novos derivados de pirimidinas
ME02144B (me) * 2010-12-20 2015-10-20 Sigma Tau Res Switzerland Sa Jedinjenja aril triazola sa antitumorskom aktivnošću
EP2502924A1 (en) 2011-03-24 2012-09-26 Chemilia AB Novel pyrimidine derivatives
MX2013010898A (es) 2011-03-24 2013-12-06 Chemilia Ab Novedoso derivados de la pirimidina.
WO2013067162A1 (en) 2011-11-02 2013-05-10 Synta Pharmaceuticals Corp. Cancer therapy using a combination of hsp90 inhibitors with topoisomerase i inhibitors
AU2012332424A1 (en) 2011-11-02 2014-06-05 Synta Pharmaceuticals Corp. Combination therapy of Hsp90 inhibitors with platinum-containing agents
WO2013074594A1 (en) 2011-11-14 2013-05-23 Synta Pharmaceuticals Corp. Combination therapy of hsp90 inhibitors with braf inhibitors
EP2711365A1 (en) 2012-09-21 2014-03-26 Chemilia AB 4-Indazolylamino-2-(2-(indol-3-yl)ethyl)aminopyrimidines useful for the treatment of cancer
EP2711364A1 (en) 2012-09-21 2014-03-26 Chemilia AB 4-(Indolyl or benzimidazolyl)amino-2-(2-(indol-3-yl)ethyl)aminopyrimidines useful for the treatment of cancer
AU2013370422A1 (en) 2012-12-28 2015-07-02 The Board Of Trustees Of The University Of Arkansas Indole compounds for use in treating inflammation and cancer
MX2015014470A (es) 2013-04-19 2016-02-22 Univ Arkansas Analogos de combretastatina.
AU2015240880A1 (en) 2014-03-31 2016-09-15 Bioventures, Llc Disubstituted triazole analogs
EP2944635B1 (en) * 2014-05-15 2018-11-28 Council of Scientific & Industrial Research Pyrazole linked benzimidazole conjugates and a process for preparation thereof
EP3448380B1 (en) 2016-04-27 2021-12-01 University Of Puerto Rico 1,5-disubstituted 1,2,3-triazoles are inhibitors of rac/cdc42 gtpases
WO2018144910A1 (en) 2017-02-02 2018-08-09 Bioventures, Llc Methods of protecting against neurodegeneration
CN109456312B (zh) * 2018-10-29 2021-06-04 郑州大学 1,2,3-三氮唑类微管蛋白聚合抑制剂其合成方法和应用
US11894884B2 (en) 2019-09-25 2024-02-06 Alarm.Com Incorporated Modular electrical grid communications platform
WO2022006377A2 (en) 2020-07-02 2022-01-06 Mbq Pharma Heterocyclic inhibitors of rho gtpases for the treatment of disease
AU2023273729A1 (en) * 2022-05-20 2024-12-05 University Of Puerto Rico 1,4,5-trisubstituted-1,2,3-triazoles and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0027987D0 (en) 2000-11-16 2001-01-03 Smithkline Beecham Plc Compounds
JP2004532234A (ja) 2001-04-27 2004-10-21 バーテックス ファーマシューティカルズ インコーポレイテッド トリアゾール由来キナーゼインヒビターおよびその使用
MXPA04012959A (es) 2002-06-29 2005-05-16 Zentaris Gmbh Arilcarbonilpiperacinas y heteroarilcarbonilpiperacinas y su uso para tratamiento de enfermedades de tumor benigno y maligno.
JP2006502236A (ja) 2002-09-18 2006-01-19 ファイザー・プロダクツ・インク 形質転換成長因子(tgf)阻害剤としてのトリアゾール誘導体
GB0315111D0 (en) 2003-06-27 2003-07-30 Cancer Rec Tech Ltd Substituted 5-membered ring compounds and their use
ITRM20030355A1 (it) * 2003-07-18 2005-01-19 Sigma Tau Ind Farmaceuti Composti ad attivita' citotossica derivati della combretastatina.
JP5149177B2 (ja) 2005-07-25 2013-02-20 シンタ ファーマシューティカルズ コーポレーション 増殖性疾患の治療のための、チューブリンポリマー化の1,2,3−トリアゾール系抑制剤

Similar Documents

Publication Publication Date Title
JP2010031025A5 (cg-RX-API-DMAC10.html)
JP2010521485A5 (cg-RX-API-DMAC10.html)
AR070522A1 (es) Derivados de pirido 4,3-d-pirimidinona como inhibidores de cinasa, una composicion farmaceutica y un metodo para el tratamient0 de una enfermedad, un medicamento en base al compuesto y el uso de este para la fabricacion de un medicamento
JP2022505835A5 (cg-RX-API-DMAC10.html)
JP2008525416A5 (cg-RX-API-DMAC10.html)
RU2011140219A (ru) Пролекарства интерферона альфа на носителе
JP2016529324A5 (cg-RX-API-DMAC10.html)
PE20141209A1 (es) Inhibidores de la replicacion de virus influenza
JP2007511527A5 (cg-RX-API-DMAC10.html)
AR072688A1 (es) Nucleosidos y nucleotidos biciclicos como agentes terapeuticos
JP2019537599A5 (cg-RX-API-DMAC10.html)
JP2010527913A5 (cg-RX-API-DMAC10.html)
JP2012513409A5 (cg-RX-API-DMAC10.html)
CA2445190A1 (en) Indole, azaindole and related heterocyclic amidopiperazine derivatives
PE20090216A1 (es) Compuestos triazolil aminopirimidina
JP2014528466A5 (cg-RX-API-DMAC10.html)
JP2009500424A5 (cg-RX-API-DMAC10.html)
JP2013500304A5 (cg-RX-API-DMAC10.html)
RU2013130256A (ru) Новые циклоспориновые производные для лечения и предупреждения вирусных инфекций
JP2010500962A5 (cg-RX-API-DMAC10.html)
JP2009535307A5 (cg-RX-API-DMAC10.html)
IL276711B2 (en) Arginase inhibitors and methods of use thereof
JP2007534702A5 (cg-RX-API-DMAC10.html)
JP2011513410A5 (cg-RX-API-DMAC10.html)
JP2010501478A5 (cg-RX-API-DMAC10.html)